Today: 26 December 2025
Subscribe

Intel Stock News Today (Dec. 20, 2025): Nvidia’s $5B Deal Clears, Intel Foundry Hits a Key 14A Milestone, and What Wall Street Forecasts for INTC

Intel Stock News Today (Dec. 20, 2025): Nvidia’s $5B Deal Clears, Intel Foundry Hits a Key 14A Milestone, and What Wall Street Forecasts for INTC

December 20, 2025 — Intel Corporation (NASDAQ: INTC) heads into the final stretch of 2025 with two narratives colliding: a high-profile partnership boost that removes a major regulatory overhang, and a “show-me” execution story that still hinges on foundry credibility,
20 December 2025
······
Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital Corporation Stock (APLD): Latest News, Earnings Outlook, Analyst Forecasts, and Key Risks as of Dec. 20, 2025

Applied Digital Corporation (NASDAQ: APLD) is ending the week the way only an AI-infrastructure “picks-and-shovels” stock can: with a bruising selloff, a sharp rebound, and investors arguing about whether the company is building the future—or building a debt tower during
20 December 2025
·····
Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Eli Lilly (LLY) Stock Outlook on Dec. 20, 2025: Orforglipron Pill Data, Price Cuts, and 2026 Forecasts Put the $1 Trillion Drugmaker Back in Focus

Dec. 20, 2025 — Eli Lilly and Company (NYSE: LLY) is closing out 2025 with momentum—and with fresh headlines that underscore why Eli Lilly stock has become one of the market’s most closely watched healthcare names. Shares last closed at
20 December 2025
·····
BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin (BMRN) Stock Surges on $4.8B Amicus Deal: Latest News, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ended Friday’s session sharply higher after announcing a blockbuster rare-disease acquisition that immediately reframed the company’s growth story. Shares closed at $61.15, up about 17.7% on the day, with trading volume far above typical levels—classic
20 December 2025
····
Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival Corporation & plc Stock (NYSE: CCL) Jumps on Dividend Return, Record FY2025 Results, and a 2026 Outlook That Has Analysts Repricing the Cruise Giant

Carnival Corporation & plc stock is closing out 2025 with the kind of headline stack investors usually reserve for a comeback movie: record full‑year profit and revenue, investment‑grade leverage metrics, the first dividend in more than five years, and a
20 December 2025
·····
Western Digital Stock (NASDAQ: WDC) News and Forecast for Dec. 20, 2025: Nasdaq-100 Inclusion, Analyst Upgrades, and the AI Storage Supercycle

Western Digital Stock (NASDAQ: WDC) News and Forecast for Dec. 20, 2025: Nasdaq-100 Inclusion, Analyst Upgrades, and the AI Storage Supercycle

December 20, 2025 — Western Digital Corporation (NASDAQ: WDC) is closing out 2025 as one of the market’s most talked-about “infrastructure for AI” plays, with shares hovering around $181 after a volatile, high-volume session that saw the stock trade between
20 December 2025
····
Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Corporation (NASDAQ: RKLB) closed at a fresh all-time high on Friday, December 19, after landing its largest contract to date: a major U.S. Space Force-linked award to build missile-defense satellites for the Space Development Agency (SDA). The move
20 December 2025
·····
Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics, Inc. (Nasdaq: EWTX) is ending mid-December 2025 in classic clinical-stage biotech fashion: big percentage swings, a sharp momentum breakout, and investors trying to decide whether the move is “new information” or simply “new positioning.” As of Saturday, December
20 December 2025
····
1 … 158 159 160 161 162 … 1,498
Go toTop